Unknown

Dataset Information

0

Bayesian Machine Learning Model Guiding Iterative, Personalized Anticoagulant Dosing Decision-Making : ENGAGE AF-TIMI 48 Trial Analysis

ABSTRACT:

SUBMITTER: Gibson C 

PROVIDER: S-EPMC12948610 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48.
| S-EPMC6490822 | biostudies-literature
Unknown Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48.
| S-EPMC4048534 | biostudies-literature
Unknown Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial.
| S-EPMC5015407 | biostudies-literature
Unknown Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial.
| S-EPMC7758931 | biostudies-literature
Unknown Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
| S-EPMC4889207 | biostudies-literature
Unknown Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
| S-EPMC5586309 | biostudies-literature
Unknown Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
| S-EPMC7884089 | biostudies-literature
Unknown Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
| S-EPMC6363338 | biostudies-literature
Unknown Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
| S-EPMC8599897 | biostudies-literature
Unknown An Adaptive Bayesian Design for Personalized Dosing in a Cancer Prevention Trial.
| S-EPMC7531353 | biostudies-literature